Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Washington Marriott Wardman Park

Oct 29, 2014 8:00 AM - Oct 30, 2014 4:00 PM

2660 Woodley Road, NW, , Washington, DC 20008 , USA

Patient Engagement throughout the Full Spectrum of Drug Development: An Interactive Workshop for Life Science Companies and Patient Groups

Session 2: A Shared Vision for Patient Engagement: Stakeholder Perspectives

Session Chair(s)

Richard  Klein

Richard Klein

Director, Expanded Access Programs & Policy, Former FDA, Patient Liaison

GE2P2 Global Foundation, United States

The ultimate goal of patient engagement in the process of developing medical products is to achieve the best possible outcome for the patient. Patients, researchers, and regulators all share this vision, but each stakeholder has a unique perspective of the role of patient engagement in the process. Why is patient engagement important? What are its benefits? What specific efforts are key to effective engagement? What are the expected outcomes of successful patient engagement? A true, functioning partnership among the stakeholders must be based on mutual understanding of these perspectives. In this session, patient group, industry, and regulatory agency leaders will discuss their views on the need for patient engagement and expected outcomes.

Speaker(s)

Patricia  Furlong, BSN

Patient Groups' Perspective

Patricia Furlong, BSN

Parent Project Muscular Dystrophy, United States

Founding President and Chief Executive Officer

Laurie  Letvak, MD

Laurie Letvak, MD

Novartis Pharmaceuticals Corporation, United States

Head Clinical Policy and Medical Ethics

Theresa  Mullin, PhD

Regulators' Perspective

Theresa Mullin, PhD

FDA, United States

Associate Center Director - Strategic Initiatives, CDER

Panel  Discussion

Panel Discussion

All Session Speakers, United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.